activins has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bantel, H; Ding, H; Dooley, S; Ebert, MPA; Fan, C; Feng, R; Jung, K; Kroll, J; Liebe, R; Lin, T; Liu, H; Macías-Rodríguez, RU; Marx, A; Mertens, PR; Meyer, C; Munker, S; N De Toni, E; Ruiz-Margáin, A; Schiergens, T; Schierwagen, R; Shao, C; Shin, D; Ten Dijke, P; Teufel, A; Trebicka, J; Wandrer, F; Wang, H; Wang, S; Weng, HL; Wimmer, R; Yuan, X; Zhang, L | 1 |
1 other study(ies) available for activins and Acute-On-Chronic Liver Failure (ACLF)
| Article | Year |
|---|---|
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
Topics: Activins; Acute-On-Chronic Liver Failure; Adult; Aged; Animals; Blood Coagulation; Cell Line; Factor V; Female; Follistatin; Follow-Up Studies; Forkhead Transcription Factors; Gene Expression; Hepatocyte Nuclear Factor 4; Hepatocytes; Humans; Liver Failure, Acute; Liver Regeneration; Liver Transplantation; Male; Metronidazole; Mice; Middle Aged; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prothrombin; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad4 Protein; Stem Cells; Transforming Growth Factor beta1; Zebrafish | 2022 |